Total Payments
$62,719
2024 Payments
$7,026
Companies
50
Transactions
648
Medicare Patients
2,620
Medicare Billing
$304,292
Payment Breakdown by Category
Other$39,255 (62.6%)
Food & Beverage$13,813 (22.0%)
Education$3,483 (5.6%)
Consulting$3,159 (5.0%)
Travel$3,009 (4.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $39,255 | 23 | 62.6% |
| Food and Beverage | $13,813 | 602 | 22.0% |
| Education | $3,483 | 10 | 5.6% |
| Consulting Fee | $3,159 | 2 | 5.0% |
| Travel and Lodging | $3,009 | 11 | 4.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $47,003 | 154 | $0 (2024) |
| INTUITIVE SURGICAL, INC. | $4,733 | 14 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,925 | 108 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $1,577 | 61 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,458 | 70 | $0 (2024) |
| Veran Medical Technologies, Inc. | $909.31 | 3 | $0 (2020) |
| Mylan Specialty L.P. | $528.97 | 30 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $399.73 | 12 | $0 (2024) |
| United Therapeutics Corporation | $325.98 | 15 | $0 (2024) |
| Insmed, Inc. | $297.39 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $7,026 | 58 | Boehringer Ingelheim Pharmaceuticals, Inc. ($5,593) |
| 2023 | $10,620 | 76 | Boehringer Ingelheim Pharmaceuticals, Inc. ($5,741) |
| 2022 | $5,172 | 91 | Boehringer Ingelheim Pharmaceuticals, Inc. ($2,887) |
| 2021 | $8,390 | 92 | Boehringer Ingelheim Pharmaceuticals, Inc. ($7,055) |
| 2020 | $3,132 | 72 | Boehringer Ingelheim Pharmaceuticals, Inc. ($2,068) |
| 2019 | $20,820 | 129 | Boehringer Ingelheim Pharmaceuticals, Inc. ($19,118) |
| 2018 | $6,450 | 78 | Boehringer Ingelheim Pharmaceuticals, Inc. ($4,303) |
| 2017 | $1,110 | 52 | GlaxoSmithKline, LLC. ($402.71) |
All Payment Transactions
648 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/21/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $39.29 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/19/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $26.02 | General |
| Category: NEUROLOGY | ||||||
| 12/16/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $22.78 | General |
| Category: Inflammation | ||||||
| 12/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $31.94 | General |
| Category: RESPIRATORY | ||||||
| 12/10/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: Respiratory | ||||||
| 12/03/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: Respiratory | ||||||
| 12/02/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $28.73 | General |
| Category: Respiratory | ||||||
| 11/29/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $23.95 | General |
| Category: RESPIRATORY | ||||||
| 11/04/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $15.50 | General |
| Category: HFCWO | ||||||
| 10/31/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: RESPIRATORY | ||||||
| 10/29/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $23.11 | General |
| Category: IMMUNOLOGY | ||||||
| 10/28/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $34.07 | General |
| Category: RESPIRATORY | ||||||
| 10/16/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: IMMUNOLOGY | ||||||
| 10/15/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $37.04 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/09/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $31.04 | General |
| Category: IMMUNOLOGY | ||||||
| 09/30/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $28.10 | General |
| Category: Respiratory | ||||||
| 09/17/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: Cardiology | ||||||
| 09/16/2024 | Tactile Systems Technology Inc | Flexitouch Plus (Device), Entre Plus | Food and Beverage | In-kind items and services | $33.06 | General |
| Category: PNEUMATIC COMPRESSOR | ||||||
| 09/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $30.14 | General |
| Category: IMMUNOLOGY | ||||||
| 08/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,800.00 | General |
| 08/19/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $33.18 | General |
| Category: Respiratory | ||||||
| 08/15/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: RESPIRATORY | ||||||
| 08/14/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: Respiratory | ||||||
| 08/07/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $35.72 | General |
| Category: Pulmonology | ||||||
| 07/31/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $31.12 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 745 | 949 | $331,752 | $78,866 |
| 2022 | 14 | 668 | 851 | $314,847 | $76,040 |
| 2021 | 13 | 621 | 857 | $331,938 | $83,461 |
| 2020 | 14 | 586 | 746 | $258,700 | $65,924 |
Total Patients
2,620
Total Services
3,403
Medicare Billing
$304,292
Procedure Codes
55
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 162 | 248 | $95,962 | $23,584 | 24.6% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 53 | 119 | $80,257 | $19,463 | 24.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 105 | 105 | $52,931 | $12,930 | 24.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 75 | 85 | $23,256 | $5,343 | 23.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 29 | 41 | $14,450 | $3,772 | 26.1% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 73 | 82 | $13,934 | $3,524 | 25.3% |
| 31653 | Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 3 or more lymph nodes | Facility | 2023 | 11 | 11 | $17,295 | $2,085 | 12.1% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 73 | 81 | $7,174 | $1,689 | 23.5% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 40 | 41 | $5,352 | $1,314 | 24.5% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 42 | 52 | $5,300 | $1,253 | 23.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 15 | 15 | $5,085 | $1,187 | 23.3% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 27 | 27 | $4,455 | $1,160 | 26.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 13 | 15 | $3,542 | $870.66 | 24.6% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 27 | 27 | $2,759 | $690.56 | 25.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 144 | 228 | $89,298 | $22,363 | 25.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 42 | 103 | $82,915 | $17,579 | 21.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 107 | 107 | $54,134 | $13,688 | 25.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 74 | 77 | $21,252 | $5,168 | 24.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 36 | 54 | $16,254 | $4,345 | 26.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 16 | 16 | $9,408 | $2,356 | 25.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 24 | 24 | $8,136 | $1,967 | 24.2% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 62 | 66 | $6,534 | $1,727 | 26.4% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 33 | 36 | $5,832 | $1,698 | 29.1% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2022 | 13 | 14 | $5,040 | $1,211 | 24.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 18 | 20 | $4,200 | $1,121 | 26.7% |
About Dr. Simha Jagadeesh, MD
Dr. Simha Jagadeesh, MD is a Critical Care Medicine healthcare provider based in Alpharetta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/30/2008. The National Provider Identifier (NPI) number assigned to this provider is 1639337272.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Simha Jagadeesh, MD has received a total of $62,719 in payments from pharmaceutical and medical device companies, with $7,026 received in 2024. These payments were reported across 648 transactions from 50 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($39,255).
As a Medicare-enrolled provider, Jagadeesh has provided services to 2,620 Medicare beneficiaries, totaling 3,403 services with total Medicare billing of $304,292. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Ad
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Critical Care Medicine, Pulmonary Disease
- Location Alpharetta, GA
- Active Since 05/30/2008
- Last Updated 04/26/2021
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1639337272
Products in Payments
- OFEV (Drug) $6,613
- Da Vinci Surgical System (Device) $4,733
- Spin (Device) $909.31
- TRELEGY ELLIPTA (Drug) $833.75
- UPTRAVI (Drug) $830.16
- OPSUMIT (Drug) $560.23
- NUCALA (Biological) $499.27
- STIOLTO RESPIMAT (Drug) $399.52
- DUPIXENT (Biological) $396.96
- TEZSPIRE (Biological) $395.32
- Yupelri (Drug) $347.85
- Arikayce (Drug) $297.39
- ACTHAR (Biological) $276.25
- FASENRA (Drug) $269.76
- BREZTRI (Drug) $215.93
- ELIQUIS (Drug) $213.41
- The Vest System Model 105 Home Care (Device) $205.46
- FASENRA (Biological) $188.74
- OPSUMIT MACITENTAN (Drug) $186.75
- SYMBICORT (Drug) $182.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.